Please use this identifier to cite or link to this item:
Title: Hypertrophic cardiomyopathy
Authors: ANTUNES, Murillo de OliveiraSCUDELER, Thiago Luis
Citation: IJC HEART & VASCULATURE, v.27, article ID 100503, 12p, 2020
Abstract: Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease. The disease is characterized by marked variability in morphological expression and natural history, ranging from asymptomatic to heart failure or sudden cardiac death. Left ventricular hypertrophy and abnormal ventricular configuration result in dynamic left ventricular outflow obstruction in most patients. The goal of pharmacological therapy in HCM is to alleviate the symptoms, and it includes pharmacotherapies and septal reduction therapies. In this review, we summarize the relevant clinical issues and treatment options of HCM. (C) 2020 The Authors.
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/InCor
Instituto do Coração - HC/InCor

Files in This Item:
File Description SizeFormat 
art_ANTUNES_Hypertrophic_cardiomyopathy_2020.PDFpublishedVersion (English)2.3 MBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.